337 related articles for article (PubMed ID: 16182742)
1. One hundred sixteen cases of acute liver failure treated with MARS.
Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB
Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742
[TBL] [Abstract][Full Text] [Related]
2. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
[TBL] [Abstract][Full Text] [Related]
3. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
[TBL] [Abstract][Full Text] [Related]
5. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
[TBL] [Abstract][Full Text] [Related]
6. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL
Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
[TBL] [Abstract][Full Text] [Related]
7. Mars and Prometheus: our clinical experience in acute chronic liver failure.
Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of efficacy and safety of using molecular adsorbent recirculating system in the treatment of patients with chronic liver failure].
Lu XB; Xiao L; Zhang YX; Liu H; Yan GX; Xu L; Sun LH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):44-6. PubMed ID: 17207365
[TBL] [Abstract][Full Text] [Related]
9. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berloco P; Ferretti G; Iappelli M; Cortesini R
Liver; 2002; 22 Suppl 2():43-7. PubMed ID: 12220303
[TBL] [Abstract][Full Text] [Related]
10. MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
Wolff B; Machill K; Schumacher D; Schulzki I
Liver Transpl; 2007 Aug; 13(8):1189-92. PubMed ID: 17663393
[TBL] [Abstract][Full Text] [Related]
11. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure.
Schmidt LE; Sørensen VR; Svendsen LB; Hansen BA; Larsen FS
Liver Transpl; 2001 Dec; 7(12):1034-9. PubMed ID: 11753905
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
[TBL] [Abstract][Full Text] [Related]
14. Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China.
Wang MM; Chen SJ; Ye QF; Yang YJ; Chen SB; Zhou XM; Guo LM; Zhang YX; Ding XQ; Hu XB; Luo HT; Liu YH; Wang WY
Chin Med J (Engl); 2008 Nov; 121(21):2197-201. PubMed ID: 19080184
[TBL] [Abstract][Full Text] [Related]
15. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
16. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
[TBL] [Abstract][Full Text] [Related]
18. Primary nonfunction: timing retransplantation versus hemodynamic parameters and kidney function.
Novelli G; Rossi M; Poli L; Morabito V; Bussotti A; Pugliese F; Ruberto F; Novelli S; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1854-7. PubMed ID: 18675069
[TBL] [Abstract][Full Text] [Related]
19. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
